Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Bharat Immunological & Biological Corporation Ltd (BIBCL) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Oral Polio VaccineManufacture and supply of Oral Polio Vaccine for national immunization programs.Government backing, WHO GMP compliance, established presence in polio vaccine supply chain.Government health agencies (B2G) for immunisation programs.Not specified; segment shows operational losses currently.44100Government procurement contracts; sales to Ministry of Health.Contract-based pricing with government; non-recurring bidding and orders.Continued government demand for polio eradication and immunization efforts.Oral Polio Vaccine (OPV)
Zinc TabletsManufacture of Zinc tablets for diarrhea management and supplementation.State-supported production line; supplements key health programs.Government health programs (B2G) targeting child health improvement.Small scale currently; potential growth area.00Sales primarily through government supply chains.Government contracts, subsidized distribution model.Rising focus on child health and diarrhea treatment measures.Zinc Tablets

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions